Milind Javle, MD, The University of Texas MD Anderson Cancer Center
Articles by Milind Javle, MD, The University of Texas MD Anderson Cancer Center

Advanced Cholangiocarcinoma: Current Patient Prognosis
ByJohn L. Marshall, MD, Georgetown University,R. Kate Kelley, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Sameek Roychowdhury, MD, PhD, James Cancer Hospital & Solove Research Institute,Milind Javle, MD, The University of Texas MD Anderson Cancer Center GI oncologists react to a prognosis for patients with newly diagnosed advanced cholangiocarcinoma and discuss how they counsel patients on goals of care and treatment expectations.

Cholangiocarcinoma: Importance of Adequate Tissue Collection
ByJohn L. Marshall, MD, Georgetown University,R. Kate Kelley, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Sameek Roychowdhury, MD, PhD, James Cancer Hospital & Solove Research Institute,Milind Javle, MD, The University of Texas MD Anderson Cancer Center Best practices for working with other colleagues to ensure adequate tissue collection occurs when conducting a biopsy on a patient suspected of having cholangiocarcinoma, as well as considerations for next-generation sequencing.

Cholangiocarcinoma: Appropriate Diagnostic Work-Up
ByJohn L. Marshall, MD, Georgetown University,R. Kate Kelley, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Sameek Roychowdhury, MD, PhD, James Cancer Hospital & Solove Research Institute,Milind Javle, MD, The University of Texas MD Anderson Cancer Center Types of assessments that are used to help appropriately work up a patient suspected of having a bile duct cancer.

Rising Incidence of Cholangiocarcinoma
ByJohn L. Marshall, MD, Georgetown University,R. Kate Kelley, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Sameek Roychowdhury, MD, PhD, James Cancer Hospital & Solove Research Institute,Milind Javle, MD, The University of Texas MD Anderson Cancer Center Factors that may contribute to the rise in the number of cholangiocarcinoma cases being reported, as suggested by GI oncologists.

Heterogeneous Nature of Cholangiocarcinoma
ByJohn L. Marshall, MD, Georgetown University,R. Kate Kelley, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Sameek Roychowdhury, MD, PhD, James Cancer Hospital & Solove Research Institute,Milind Javle, MD, The University of Texas MD Anderson Cancer Center GI oncologists explain the complicated nature of cholangiocarcinoma as it relates to the disease’s underlying pathogenesis.

Cholangiocarcinoma Described
ByJohn L. Marshall, MD, Georgetown University,R. Kate Kelley, MD, UCSF Helen Diller Family Comprehensive Cancer Center,Sameek Roychowdhury, MD, PhD, James Cancer Hospital & Solove Research Institute,Milind Javle, MD, The University of Texas MD Anderson Cancer Center Dr Sameek Roychowdhury, of the James Cancer Hospital Solove Research Institute, describes what cholangiocarcinoma is, specifically highlighting how the disease often presents in patients.